Vanessa K. Hinson

Title
InstitutionMedical University of South Carolina
DepartmentNeurology
AddressP.O. Box MSC 108
1
208-B Rutledge Ave. - 208-B Rutledge Ave.
Phone843-792-7262
Fax843-792-1751
vCardDownload vCard

    Collapse Overview 
    Collapse keywords
    Brain, Movement Disorders, Aging, Exercise, Geriatrics, Drug Studies, Parkinsons

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Chen T, Edwards TS, Hinson VK, Soler ZM. Prevalence of Rhinorrhea in Parkinson Disease: A Systematic Review and Meta-analysis. Neurol Clin Pract. 2022 Aug; 12(4):e75-e81. PMID: 36382119; PMCID: PMC9647823.
      Citations:    
    2. Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, McMahon GM, Pothier L, Waikar SS, Lang A, Mestre T, Parkinson Study Group SURE-PD3 Investigators, Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, McMahon GM, Pothier L, Waikar SS, Lang A, Mestre T. Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial. JAMA. 2021 09 14; 326(10):926-939. PMID: 34519802; PMCID: PMC8441591.
      Citations:    
    3. Farrand AQ, Verner RS, McGuire RM, Helke KL, Hinson VK, Boger HA, Farrand AQ, Verner RS, McGuire RM, Helke KL, Hinson VK, Boger HA. Differential effects of vagus nerve stimulation paradigms guide clinical development for Parkinson's disease. Brain Stimul. 2020 Sep - Oct; 13(5):1323-1332. PMID: 32629028.
      Citations:    
    4. Farrand AQ, Helke KL, Aponte-Cofresí L, Gooz MB, Gregory RA, Hinson VK, Boger HA, Farrand AQ, Helke KL, Aponte-Cofres? L, Gooz MB, Gregory RA, Hinson VK, Boger HA. Effects of vagus nerve stimulation are mediated in part by TrkB in a parkinson's disease model. Behav Brain Res. 2019 11 05; 373:112080. PMID: 31301412; PMCID: PMC6701465.
      Citations:    
    5. Farrand AQ, Helke KL, Gregory RA, Gooz M, Hinson VK, Boger HA, Farrand AQ, Helke KL, Gregory RA, Gooz M, Hinson VK, Boger HA. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease. Brain Stimul. 2017 Nov - Dec; 10(6):1045-1054. PMID: 28918943; PMCID: PMC5675746.
      Citations:    
    6. Turner TH, Renfroe JB, Duppstadt-Delambo A, Hinson VK, Turner TH, Renfroe JB, Duppstadt-Delambo A, Hinson VK. Validation of a Behavioral Approach for Measuring Saccades in Parkinson's Disease. J Mot Behav. 2017 Nov-Dec; 49(6):657-667. PMID: 28139169.
      Citations:    
    7. Renfroe JB, Turner TH, Hinson VK, Renfroe JB, Turner TH, Hinson VK. Assessing Visuospatial Skills in Parkinson's: Comparison of Neuropsychological Assessment Battery Visual Discrimination to the Judgment of Line Orientation. Arch Clin Neuropsychol. 2017 Feb; 32(1):123-127. PMID: 28122771.
      Citations:    
    8. Hinson VK, Delambo A, Elm J, Turner T, Hinson VK, Delambo A, Elm J, Turner T. A Randomized Clinical Trial of Atomoxetine for Mild Cognitive Impairment in Parkinson's Disease. Mov Disord Clin Pract. 2017 May-Jun; 4(3):416-423. PMID: 30363371; PMCID: PMC6174374.
      Citations:    
    9. Wills AA, Elm JJ, Ye R, Chou KL, Parashos SA, Hauser RA, Bodis-Wollner I, Hinson VK, Christine CW, Schneider JS, Wills AA, Elm JJ, Ye R, Chou KL, Parashos SA, Hauser RA, Bodis-Wollner I, Hinson VK, Christine CW, Schneider JS, NINDS NET-PD Investigators. Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1. Parkinsonism Relat Disord. 2016 12; 33:127-133. PMID: 27743701; PMCID: PMC6091572.
      Citations:    
    10. Turner TH, Renfroe JB, Elm J, Duppstadt-Delambo A, Hinson VK, Turner TH, Renfroe JB, Elm J, Duppstadt-Delambo A, Hinson VK. Robustness of reliable change indices to variability in Parkinson's disease with mild cognitive impairment. Appl Neuropsychol Adult. 2016 Nov-Dec; 23(6):399-402. PMID: 27144494.
      Citations:    
    11. Revuelta GJ, Embry A, Elm JJ, Gregory C, Delambo A, Kautz S, Hinson VK, Revuelta GJ, Embry A, Elm JJ, Gregory C, Delambo A, Kautz S, Hinson VK. Pilot study of atomoxetine in patients with Parkinson's disease and dopa-unresponsive Freezing of Gait. Transl Neurodegener. 2015; 4:24. PMID: 26693006; PMCID: PMC4676139.
      Citations:    
    12. Ledreux A, Boger HA, Hinson VK, Cantwell K, Granholm AC, Ledreux A, Boger HA, Hinson VK, Cantwell K, Granholm AC. BDNF levels are increased by aminoindan and rasagiline in a double lesion model of Parkinson?s disease. Brain Res. 2016 Jan 15; 1631:34-45. PMID: 26607251.
      Citations:    
    13. Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K, Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurol. 2014 May; 71(5):543-52. PMID: 24664227.
      Citations:    
    14. Kompoliti K, Wilson B, Stebbins G, Bernard B, Hinson V, Kompoliti K, Wilson B, Stebbins G, Bernard B, Hinson V. Immediate vs. delayed treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: randomized clinical trial. Parkinsonism Relat Disord. 2014 Jan; 20(1):60-3. PMID: 24120952.
      Citations:    
    15. Zesiewicz TA, Sullivan KL, Hinson V, Stover NP, Fang J, Jahan I, Miller A, Carranza MA, Elble R, Zesiewicz TA, Sullivan KL, Hinson V, Stover NP, Fang J, Jahan I, Miller A, Carranza MA, Elble R. Multisite, double-blind, randomized, controlled study of pregabalin for essential tremor. Mov Disord. 2013 Feb; 28(2):249-50. PMID: 23238907.
      Citations:    
    16. Turner TH, Hinson V, Turner TH, Hinson V. Mattis Dementia Rating Scale cutoffs are inadequate for detecting dementia in Parkinson's disease. Appl Neuropsychol Adult. 2013; 20(1):61-5. PMID: 23373686.
      Citations:    
    17. Gaines KD, Hinson VK, Gaines KD, Hinson VK. Adjunctive therapy in Parkinson's disease: the role of rasagiline. Neuropsychiatr Dis Treat. 2012; 8:285-94. PMID: 22802692; PMCID: PMC3395407.
      Citations:    
    18. de Vries PM, de Jong BM, Bohning DE, Hinson VK, George MS, Leenders KL, de Vries PM, de Jong BM, Bohning DE, Hinson VK, George MS, Leenders KL. Reduced parietal activation in cervical dystonia after parietal TMS interleaved with fMRI. Clin Neurol Neurosurg. 2012 Sep; 114(7):914-21. PMID: 22386903.
      Citations:    
    19. Elm JJ, Palesch YY, Koch GG, Hinson V, Ravina B, Zhao W, Elm JJ, Palesch YY, Koch GG, Hinson V, Ravina B, Zhao W. Flexible analytical methods for adding a treatment arm mid-study to an ongoing clinical trial. J Biopharm Stat. 2012; 22(4):758-72. PMID: 22651113; PMCID: PMC3770292.
      Citations:    
    20. Hinson VK, Hinson VK. Parkinson's disease and motor fluctuations. Curr Treat Options Neurol. 2010 May; 12(3):186-99. PMID: 20842581.
      Citations:    
    21. Hinson VK, Goetz CG, Leurgans S, Fan W, Nguyen T, Hsu A, Hinson VK, Goetz CG, Leurgans S, Fan W, Nguyen T, Hsu A. Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients. Clin Neuropharmacol. 2009 Jul-Aug; 32(4):189-92. PMID: 19620848.
      Citations:    
    22. Evatt ML, Chaudhuri KR, Chou KL, Cubo E, Hinson V, Kompoliti K, Yang C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG, Evatt ML, Chaudhuri KR, Chou KL, Cubo E, Hinson V, Kompoliti K, Yang C, Poewe W, Rascol O, Sampaio C, Stebbins GT, Goetz CG. Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease. Mov Disord. 2009 Apr 15; 24(5):635-46. PMID: 19205066; PMCID: PMC4404514.
      Citations:    
    23. Goetz CG, Leurgans S, Hinson VK, Blasucci LM, Zimmerman J, Fan W, Nguyen T, Hsu A, Goetz CG, Leurgans S, Hinson VK, Blasucci LM, Zimmerman J, Fan W, Nguyen T, Hsu A. Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments. Mov Disord. 2008 Jul 30; 23(10):1479-82. PMID: 18512751.
      Citations:    
    24. Bonilha L, de Vries PM, Hurd MW, Rorden C, Morgan PS, Besenski N, Bergmann KJ, Hinson VK, Bonilha L, de Vries PM, Hurd MW, Rorden C, Morgan PS, Besenski N, Bergmann KJ, Hinson VK. Disrupted thalamic prefrontal pathways in patients with idiopathic dystonia. Parkinsonism Relat Disord. 2009 Jan; 15(1):64-7. PMID: 18358756.
      Citations:    
    25. Chou KL, Evatt M, Hinson V, Kompoliti K, Chou KL, Evatt M, Hinson V, Kompoliti K. Sialorrhea in Parkinson's disease: a review. Mov Disord. 2007 Dec; 22(16):2306-13. PMID: 17659637.
      Citations:    
    26. Bonilha L, de Vries PM, Vincent DJ, Rorden C, Morgan PS, Hurd MW, Besenski N, Bergmann KJ, Hinson VK, Bonilha L, de Vries PM, Vincent DJ, Rorden C, Morgan PS, Hurd MW, Besenski N, Bergmann KJ, Hinson VK. Structural white matter abnormalities in patients with idiopathic dystonia. Mov Disord. 2007 Jun 15; 22(8):1110-6. PMID: 17230463.
      Citations:    
    27. Hinson VK, Haren WB, Hinson VK, Haren WB. Psychogenic movement disorders. Lancet Neurol. 2006 Aug; 5(8):695-700. PMID: 16857575.
      Citations:    
    28. Vincent DJ, Bloomer CJ, Hinson VK, Bergmann KJ, Vincent DJ, Bloomer CJ, Hinson VK, Bergmann KJ. The range of motor activation in the normal human cortex using bold FMRI. Brain Topogr. 2006; 18(4):273-80. PMID: 16845593.
      Citations:    
    29. Orr RK, Hoehn JL, Col NF, Hinson VK, Weinstein S, Bernard B, Leurgans SE, Goetz CG. Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders. Parkinsonism Relat Disord. 2006 Apr; 12(3):177-80. PMID: 16364676.
      Citations:    
    30. Hinson VK, Cubo E, Comella CL, Goetz CG, Leurgans S, Hinson VK, Cubo E, Comella CL, Goetz CG, Leurgans S. Rating scale for psychogenic movement disorders: scale development and clinimetric testing. Mov Disord. 2005 Dec; 20(12):1592-7. PMID: 16108025.
      Citations:    
    31. Cubo E, Hinson VK, Goetz CG, Garcia Ruiz P, Garcia de Yebenes J, Marti MJ, Rodriguez Oroz MC, Linazasoro G, Chacón J, Vázquez A, López del Val J, Leurgans S, Wuu J, Cubo E, Hinson VK, Goetz CG, Garcia Ruiz P, Garcia de Yebenes J, Marti MJ, Rodriguez Oroz MC, Linazasoro G, Chac?n J, V?zquez A, L?pez del Val J, Leurgans S, Wuu J. Transcultural comparison of psychogenic movement disorders. Mov Disord. 2005 Oct; 20(10):1343-5. PMID: 16001406.
      Citations:    
    32. Hinson VK, Goetz CG, Hinson VK, Goetz CG. Torsion Dystonia in Children. Curr Treat Options Neurol. 2003 Jul; 5(4):291-297. PMID: 12791196.
      Citations:    
    33. Goetz CG, Hinson VK, Goetz CG, Hinson VK. Therapies for movement disorders. Arch Neurol. 2002 May; 59(5):699-702. PMID: 12020248.
      Citations:    Fields:    Translation:Humans
    34. Hinson VK, Tyor WR, Hinson VK, Tyor WR. Update on viral encephalitis. Curr Opin Neurol. 2001 Jun; 14(3):369-74. PMID: 11371762.
      Citations: 16     Fields:    Translation:HumansPHPublic Health
    Hinson's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (166)
    Explore
    _
    Co-Authors (16)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _